COVID-19 Vaccine

As the U.S. launches a fresh round of updated COVID-19 vaccines, some patients encounter hurdles in obtaining prompt health insurance coverage for their shots. Under the recommendation of U.S. regulators, Pfizer Inc (NYSE: PFE)/ BioNTech SE (NASDAQ: BNTX) and Moderna...

The Centers for Disease Control and Prevention (CDC) has officially endorsed COVID-19 booster shots for individuals six months and older as we approach the fall season. Monday, the FDA cleared updated booster shots from Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ:...

Moderna Inc's (NASDAQ: MRNA) clinical trial data from its research assay confirm that its updated COVID-19 vaccine generates an 8.7-fold increase in neutralizing antibodies in humans against BA.2.86 (Pirola), a variant under monitoring.  The updated COVID-19 vaccine is pending...

The European Commission has approved Comirnaty XBB.1.5-adapted COVID-19 vaccine, developed by BioNTech SE (NASDAQ: BNTX)-Pfizer Inc (NYSE: PFE).  It is the third adaptation of this vaccine to respond to new COVID-19 variants. The vaccine is authorized for adults,...

The U.S. Justice Department revealed the results of an extensive crackdown on widespread COVID-19 relief fraud, shedding light on the extent of deceit and manipulation that opportunistic criminals undertook during the global pandemic. As trillions of dollars were disbursed to Americans...

On Wednesday, a U.S. District Judge denied a request by Democratic presidential candidate Robert F. Kennedy Jr. for a temporary restraining order to prevent Google, owned by  Alphabet Inc (NASDAQ:GOOGL) (NASDAQ:GOOG), from removing his videos from YouTube, citing the platform...

Moderna Inc (NASDAQ: MRNA) announced that preliminary clinical trial data confirm its updated COVID-19 vaccine for the fall 2023 vaccination season showed a significant boost in neutralizing antibodies against EG.5 and FL.1.5.1 variants.  These results suggest that Moderna's...

The European Commission has approved Novavax Inc's (NASDAQ: NVAX) Nuvaxovid (NVX-CoV2373), following a positive opinion for a full authorization from the Committee for Medicinal Products for Human Use of the European Medicines Agency.  The vaccine is now fully authorized as...

Moderna Inc (NASDAQ: MRNA) submitted a regulatory application to the European Medicines Agency (EMA) for its updated COVID-19 vaccine encoding the spike protein for the XBB.1.5 sublineage of SARS-CoV-2. The application is based on guidance from the European Centre for Disease Prevention...

As the emergency phase of the COVID-19 pandemic draws to a close, the COVAX initiative, run by Gavi, the WHO, and CEPI, reportedly has $2.6 billion left over that could be used to prepare for other pandemics or to support vaccine manufacturing in Africa. The initiative will conclude at the end of...

Thursday, the FDA's Vaccines and Related Biological Products Advisory Committee all 21 members voted "Yes," recommending that updated monovalent COVID shots in the fall and winter targeting the XBB variants, which are now the dominant strains of the SARS-CoV-2 virus in the...

Pfizer Inc (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The small biotechnology firm claims that its...

Novavax Inc's (NASDAQ: NVAX) R&D chief Filip Dubovsky expressed confidence that the company's updated COVID-19 vaccine, already in production, will offer protection against the rapidly emerging coronavirus variants prevalent in the U.S. Novavax's protein-based vaccines,...

The European Commission (EC) had agreed with BioNTech SE (NASDAQ: BNTX) and Pfizer Inc (NYSE: PFE) on adapting the existing contract on vaccines against Covid-19, including a reduction in the quantity of doses purchased by EU countries under the contract and pushing...

In an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains in line with recommendations by the World Health Organization. Last week, an advisory group for the World...